Hybrid Drug-Coated Balloon Strategy
Cross-source consensus on Hybrid Drug-Coated Balloon Strategy from 1 sources and 4 claims.
1 sources · 4 claims
Uses
How it works
Benefits
Evidence quality
Highlighted claims
- The hybrid DCB strategy uses a contemporary drug-eluting stent in the main vessel and a drug-coated balloon in the side branch. — Hybrid drug-coated balloon strategy for coronary bifurcation lesions: a systematic review and meta-analysis
- The evidence base remains uncertain despite favorable findings. — Hybrid drug-coated balloon strategy for coronary bifurcation lesions: a systematic review and meta-analysis
- The strategy is intended to avoid leaving a permanent implant in the side branch. — Hybrid drug-coated balloon strategy for coronary bifurcation lesions: a systematic review and meta-analysis
- The review found the hybrid DCB approach feasible and promising at about 12 months of clinical follow-up. — Hybrid drug-coated balloon strategy for coronary bifurcation lesions: a systematic review and meta-analysis